And this is why OBJ are STILL struggling to make a buck & demonstrate a legitimate cash flow positive 4C; as all things MicroArray atm are still either soft launch, limited country release or seasonal; after more than 5 years of products on shelves. At this rate imo, our patents will have expired and P&G will have mastered the technical know-how to mass produce; without the need for any further expertise input from OBJ or the requirement to pay royalties. Brilliant for P&G, but potentially sad for OBJ imo .
I'd feel more confident if our BoD were updating us on other fronts outside of P&G, but we haven't heard anything of value since they were up for re-election in the last half of 2018 - in fact, it was the last Investor Conference Call of 28/08/2018 (almost a year ago) where we were dangled more of the same 'what if's'...what if we had 5 seperate businesses to sell for a $100 Million each etc. Insert cricket sounds here...chirp, chirp, chirp. Apart from whispers from those who are still being charmed via the telephone, who report back here, we really haven't officially heard ANYTHING from this BoD of substance outside of P&G, apart from a random hair product on LinkedIn related to a Director's own subsidiary business, with claims of being a cure for baldness with 6 months of use, that doesn't appear to have anything to do with OBJ due to the notion that no product development plan or collaboration was announced, which would obviously be ASX Market sensitive. Insert more sounds of crickets here...chirp, chirp, chirp.
The share-price imo is obviously being held up atm and has been since the release of the last 4C. 2nd installment of 1 million for 2nd tech is still a no-show, along with any expected P&G back payments bandied around for almost a year now. OBJ's technology is hardly embedded yet into P&G's product lines. We have one SK-II integrated product that hasn't even been properly soft-launched. The rest are limited country, seasonal & promotional. Investors are growing weary, as demonstrated by OBJ's current price and and the obvious SP propping. If a capital raise or accelerator program is on it's way...and it IS imo in some form, which will provide further dilution, you have to wonder exactly what is really going on with OBJ and & why we the Shareholders are not being informed, unless we make a phone call for conveniently unverifiable dialogue?!?
- Forums
- ASX - By Stock
- WFL
- Olay Tmall Sales April 2019
Olay Tmall Sales April 2019, page-29
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online